Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit |
---|---|
6/30/2025 | $ 53K |
3/31/2025 | $ 58K |
12/31/2024 | $ 61K |
9/30/2024 | $ 63K |
6/30/2024 | $ 54K |
3/31/2024 | $ 68K |
12/31/2023 | $ 130K |
9/30/2023 | $ 48.5M |
6/30/2023 | $ 48.48M |
3/31/2023 | $ 84.19M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2025
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.34K |
---|---|
min | $ -790.38M |
max | $ 1.32B |
average | $ 245.13M |
median | $ 92.73M |
std | $ 328.2M |